Anima Biotech is pioneering Translation Control Therapeutics, a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.
Our platform addresses the widest range of diseases including where proteins are overexpressed, underexpressed or mutated.
With our proprietary technology that emits light pulses from ribosomes, we identify drug candidat...
Anima Biotech is pioneering Translation Control Therapeutics, a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.
Our platform addresses the widest range of diseases including where proteins are overexpressed, underexpressed or mutated.
With our proprietary technology that emits light pulses from ribosomes, we identify drug candidates that selectively decrease or increase the translation of proteins and elucidate their mechanism of action in a new target space.
Our pipeline includes programs in Fibrosis (tissue selective Collagen
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.